Stocks and Investing Stocks and Investing
Mon, June 14, 2021
Sun, June 13, 2021
Fri, June 11, 2021

Paul Matteis Maintained (VRTX) at Strong Buy with Decreased Target to $244 on, Jun 11th, 2021


Published on 2024-10-27 16:57:54 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Stifel, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Decreased Target from $277 to $244 on, Jun 11th, 2021.

Paul has made no other calls on VRTX in the last 4 months.



There are 2 other peers that have a rating on VRTX. Out of the 2 peers that are also analyzing VRTX, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul


  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $279 on, Wednesday, May 12th, 2021
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $260 on, Monday, May 3rd, 2021
Contributing Sources